Discover and read the best of Twitter Threads about #IBDtwitter
Most recents (5)
@MondayNightIBD 1/ 📣 #GITwitter #IBDTwitter
It’s a new🔥#Back2Basics session with #GI #Fellow @JosephHabibi_MD
Let’s talk AZA/6-MP in IBD
✅#IBDPolls 1️⃣&2️⃣👆🏽
✅Role as Mono/combo therapy
✅Escalation consideration
✅TPMT & NUDT15 testing
✅Side effects & counseling
It’s a new🔥#Back2Basics session with #GI #Fellow @JosephHabibi_MD
Let’s talk AZA/6-MP in IBD
✅#IBDPolls 1️⃣&2️⃣👆🏽
✅Role as Mono/combo therapy
✅Escalation consideration
✅TPMT & NUDT15 testing
✅Side effects & counseling
@MondayNightIBD @NavreetChowlaMD @MilestoneIBD @IBD_FloMD @tinahamd @DrCoreySiegel @HorstIBDDoc @MLongMD @LauraRaffalsMD @doc_ibd @IBDBen 2/ AZA trials in IBD:
🔹Corticosteroids needed to induce remission
🔹Takes ~12 wks for AZA/6MP to become effective, so taper steroids accordingly
🔹AZA/6-MP effective for maintenance of remission (mainly in UC); Not effective for induction
🔹Corticosteroids needed to induce remission
🔹Takes ~12 wks for AZA/6MP to become effective, so taper steroids accordingly
🔹AZA/6-MP effective for maintenance of remission (mainly in UC); Not effective for induction
@MondayNightIBD @NavreetChowlaMD @MilestoneIBD @IBD_FloMD @tinahamd @DrCoreySiegel @HorstIBDDoc @MLongMD @LauraRaffalsMD @doc_ibd @IBDBen @IBDHorizons @IBD_Houston @IrisWangMD @LoriPlung @vaibhav_manu @KatieFalloonMD @amneethansmd @ManuelBragaMD @Chatterjee_MD @SuhaAbushamma 3/ AZA in today’s practice
1⃣CS-sparing monotherapy for maintenance of moderate IBD
2⃣Combo w/ TNFi to
↑ TNFi levels
↓ Ab formation
2nd MOA for severe/complex IBD not responsive to mono💉
Perianal Crohn’s
...⏬
1⃣CS-sparing monotherapy for maintenance of moderate IBD
2⃣Combo w/ TNFi to
↑ TNFi levels
↓ Ab formation
2nd MOA for severe/complex IBD not responsive to mono💉
Perianal Crohn’s
...⏬
⌛️#GITwitter #PedsGI - the wait is over!
🎆 Join @valcohranmd & @DCharabaty
📽️#MNIBDWebinar🎞#ShortBowelSyndrome Consult w the Expert
#CME👉 🔗bit.ly/sbs-consult-1-…
👇#PostConvo #IBDPolls
Supported by an educational grant from @TakedaPharma twitter.com/i/broadcasts/1…
🎆 Join @valcohranmd & @DCharabaty
📽️#MNIBDWebinar🎞#ShortBowelSyndrome Consult w the Expert
#CME👉 🔗bit.ly/sbs-consult-1-…
👇#PostConvo #IBDPolls
Supported by an educational grant from @TakedaPharma twitter.com/i/broadcasts/1…
2/#PedsGI #GITwitter #GIFellow #IBDTwitter #MedEd #MedTwitter
🟠Earn #CME 🏆
🟠Full CME ℹ️ 🔗bit.ly/sbs-consult-1-…
#MNIBDWebinar #BonumCE
📸 Faculty disclosures & important CME info 👇
🟠Earn #CME 🏆
🟠Full CME ℹ️ 🔗bit.ly/sbs-consult-1-…
#MNIBDWebinar #BonumCE
📸 Faculty disclosures & important CME info 👇
3/#MNIBDWebinar #MedTwitter #GITwitter #GIFellow
🟠Full CME ℹ️ 🔗bit.ly/sbs-consult-1-…
🔴 Where are you in your career?
🟠Full CME ℹ️ 🔗bit.ly/sbs-consult-1-…
🔴 Where are you in your career?
@MondayNightIBD @DCharabaty 1/12
📣#GITwitter #IBDTwitter
Welcome back to #MondayNightIBD #Back2Basics w @dunleavy_katie @john_damianosMD
🎯How do you approach a pt w #IBD in remission who has new or persistent #GI symptoms?
Check out our review📜
practicalgastro.com/2022/05/18/rec…
#NeuroGI #GastroPsych #DGBI
📣#GITwitter #IBDTwitter
Welcome back to #MondayNightIBD #Back2Basics w @dunleavy_katie @john_damianosMD
🎯How do you approach a pt w #IBD in remission who has new or persistent #GI symptoms?
Check out our review📜
practicalgastro.com/2022/05/18/rec…
#NeuroGI #GastroPsych #DGBI
@MondayNightIBD @DCharabaty @john_damianosMD 2/12 #MondayNightIBD #B2B
👩🏼⚕️have been studying “IBS-type symptoms” in #IBD for 30 yrs. But there is more work to be done to help characterize cohort & dz mechanism!
It’s important bc:
👨👩👧👦Affects pts QoL, mental health, sleep
🥼Causes ⬆️HC utilization, ⬆️MD visits & 💊narcotics
👩🏼⚕️have been studying “IBS-type symptoms” in #IBD for 30 yrs. But there is more work to be done to help characterize cohort & dz mechanism!
It’s important bc:
👨👩👧👦Affects pts QoL, mental health, sleep
🥼Causes ⬆️HC utilization, ⬆️MD visits & 💊narcotics
@MondayNightIBD @DCharabaty @john_damianosMD @MarcelYibirin @VictorChedidMD @LauraRaffalsMD @Spencerkelley7 @RomyChamoun @JosephHabibi_MD @ayshaslam999 @GroverDheera @yaransarkis @BassiMehak 3/12 #MondayNightIBD Persistent/New GI Sx in #IBD
1⃣R/o active🔥/#IBD complication (abscess, stricture):🔦, 🩻, CRP, FCP, ⚠️R/o infx like C. Difficile!
2⃣🤔Consequences of✂️: adhesion, bile acid diarrhea
3⃣🤔 #DGBI
🚩25% pts w #IBD in endo remission have #IBS @LancetGastroHep
1⃣R/o active🔥/#IBD complication (abscess, stricture):🔦, 🩻, CRP, FCP, ⚠️R/o infx like C. Difficile!
2⃣🤔Consequences of✂️: adhesion, bile acid diarrhea
3⃣🤔 #DGBI
🚩25% pts w #IBD in endo remission have #IBS @LancetGastroHep
#IBDtwitter
In ileocecal #Crohn’s disease, typically all bowel wall layers are involved. #IUS shows marked mural thickening, predominantly in the terminal ileum, cecum & appendix can also be involved.
🔗: ncbi.nlm.nih.gov/pmc/articles/P…
In ileocecal #Crohn’s disease, typically all bowel wall layers are involved. #IUS shows marked mural thickening, predominantly in the terminal ileum, cecum & appendix can also be involved.
🔗: ncbi.nlm.nih.gov/pmc/articles/P…
Bowel wall thickening is most prominent in the hyperechoic submucosal layer, representing deposition of fat and fibrous tissue as a result of chronic bowel inflammation
🥊 #HitMeWithYourBestShot: Reguiero vs Siegel
@MRegueiroMD➕anti-TNFs "Why wouldn't we use anti-TNF as first line #IBD therapy?!"
#AIBD2021 @IBDConference @DrCoreySiegel
@MRegueiroMD➕anti-TNFs "Why wouldn't we use anti-TNF as first line #IBD therapy?!"
#AIBD2021 @IBDConference @DrCoreySiegel
Anti-TNFs are EFFECTIVE
We know a LOT about #TDM in anti-TNFs
